Summary of Key Information:

Reporting Period (Quarter/Year): Quarter ended June 30, 2026 (Q1 FY27)

Nature of Filing / Announcement: Outcome of Board Meeting - Unaudited Financial Results

Audit Opinion:

The financial results are unaudited but have been reviewed by the statutory auditors, S.R. Batliboi & Associates LLP. The review reports state that nothing has come to their attention that causes them to believe the statements contain any material misstatement. The opinion is clean and unmodified.

Auditor’s Comment:

Not Specified

Key Financial Highlights [Amount in Rs. Million]:

Consolidated Results:

Revenue from Operations: Rs 7,559.46 million for Q1 FY27, compared to Rs 5,952.54 million in Q1 FY26 (27% YoY increase) and Rs 6,570.84 million in Q4 FY26 (15% QoQ increase).

Total Income: Rs 7,784.57 million for Q1 FY27, compared to Rs 6,191.44 million in Q1 FY26 and Rs 6,759.62 million in Q4 FY26.

Net Profit: Rs 904.48 million for Q1 FY27, compared to Rs 413.25 million in Q1 FY26 (119% YoY increase) and Rs 694.38 million in Q4 FY26 (30% QoQ increase).

Profit after tax attributable to owners of the company: Rs 902.49 million for Q1 FY27.

EPS: Basic EPS of Rs 2.77 and Diluted EPS of Rs 2.76 for Q1 FY27.

Other Equity: Rs 10,864.82 million as of March 31, 2026 (Audited).

Standalone Results (Holding Company):

Revenue from Operations: Rs 6,963.18 million for Q1 FY27, compared to Rs 5,836.28 million in Q1 FY26 (19% YoY increase) and Rs 6,076.48 million in Q4 FY26 (15% QoQ increase).

Total Income: Rs 7,182.42 million for Q1 FY27.

Net Profit: Rs 843.12 million for Q1 FY27, compared to Rs 399.01 million in Q1 FY26 (111% YoY increase) and Rs 644.73 million in Q4 FY26 (31% QoQ increase).

EPS: Basic EPS of Rs 2.59 and Diluted EPS of Rs 2.58 for Q1 FY27.

Other Equity: Rs 10,707.30 million as of March 31, 2026 (Audited).

Segment-wise Performance:

The Group operates in one reportable segment: trading of beauty and personal care products. No additional segment disclosures were made.

Corporate Actions:

Dividend: The Board of Directors recommended a final dividend of Rs 3 per equity share (face value Rs 10 each) on May 21, 2026, subject to shareholder approval at the ensuing Annual General Meeting.

ESOPs: The company granted 574,400 options to employees under the "Employee stock options plan 2018" during the quarter. Subsequently, 654,422 equity shares were allotted upon exercise of stock options, increasing the paid-up share capital from Rs 3,253.70 million to Rs 3,260.24 million.

Other Significant Information:

Legal Dispute Resolution: The long-standing legal suit with RSM General Trading LLC (UAE distributor) was conclusively resolved. The Cassation Court (Highest Court of Dubai) upheld a judgment requiring the company to pay only AED 1.75 million (Rs 42.75 million), drastically lower than the initial claim of AED 45 million (Rs 1,001.25 million). Furthermore, an Indian arbitral tribunal passed an award in favor of Honasa, declaring the termination of the agreement valid and ordering RSM to pay Honasa approx. AED 9.92 million (Rs 255.36 million).

Acquisition: On June 23, 2026, the Board approved the acquisition of Fluence Pharma Private Limited. The plan is to acquire a 58% majority stake initially, followed by the remaining 42% in two tranches over the next 5-7 years. The acquisition is subject to conditions precedent and had no impact on the Q1 FY27 results.

New Subsidiary: The Board approved the incorporation of a wholly-owned subsidiary, 'Honasa Health Private Limited', on June 23, 2026, to undertake B2C operations of the company's nutraceuticals business. It was incorporated on July 7, 2026, after the quarter ended.

Exceptional Item: For the year ended March 31, 2026, the Group recognized an exceptional item of Rs 47.97 million as a past service cost related to the implementation of the new Labour Codes.

IPO Proceeds Utilization: As of June 30, 2026, Rs 3,208.34 million of the net IPO proceeds of Rs 3,504.92 million had been utilized. Key uses include Rs 1,820.00 million for advertisement expenses, Rs 1,218.92 million for general corporate purposes, Rs 91.56 million for capital expenditure (EBOs), and Rs 77.86 million for investment in subsidiary BBlunt for new salons.

Subsidiaries and Joint Venture: The consolidated results include 4 subsidiaries and 1 joint venture: Bhabani Blunt Hairdressing Private Limited, B:Blunt-Spratt Hairdressing Private Limited, Honasa Consumer General Trading LLC, PT Honasa Consumer Indonesia, BTM Ventures Private Limited (subsidiary w.e.f. January 06, 2026), and Couch Commerce Private Limited (joint venture w.e.f. December 16, 2025).